Australia's largest stock trading and investment forum Australia's #1 stock forum

REF

Click for more information

0.00%

0.3¢ reverse corp limited

Ann: Dividend/Distribution - REF, page-30

First 30 Last

Share
Profile

Follow
Patient

2,444 Posts.

213

04/09/18

05:35

Post #: 35389970
Share

Originally posted by MarsC ↑

Ok, after reading the small notes properly, and re-doing my numbers, here's what I get:

In FY16 the contact lense business was generating annual revenues of about $1.5 m. In the H1 period of FY17, annual revenues of about $0.87 m (^) were acquired (acquisition of Net Contacts). In the H1 period of FY18, annual revenues of $1.2 m (+) were acquired (acquisition of WebContacts and YourContacts). So pro-forma, and absent any organic growth, the business should now be generating annual revenues of $1.5m + $0.88m + $1.2m = $3.58m.

Fast forward to the H2 FY18 period, and annual revenue (in online contacts retailing) was reported at $4.5m. The reported H1 FY18 revenue was $2.0m, meaning H2 FY18 revenues were $2.5m, which crudely annualises to 2 x $2.5m = $5.0m.

Expand

That's a whole lot of work for someone bordering on sloth Thanks

REF Price at posting: 9.2¢ Sentiment: Hold Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

HAS

Hastings progressing Yangibana to production with lower costs

The iron ore comeback: Can it last?

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

ZNC

Zenith's sale of Develin Creek delivers $975K cash, with shares up 13%

There are more pages in this discussion • 17 more messages in this thread...

First 30 Last

Add REF (ASX) to my watchlist